Tranquil Clinical Research successfully completed a Phase II clinical trial in COVID patients.

Tranquil Clinical Research successfully completed a Phase II clinical trial in COVID patients as the CRO conducting all clinical trial operations including: Protocol development, FDA submissions/approvals,  pharmacovigilance, clinical project management, clinical operations and with the highest level of quality deliverables throughout the entirety of the study lifecycle.

Tranquil Clinical Research is in the business of innovation, servicing sponsors, patients and clients through clinical trials.

Testimonials

What our clients say about us